IgG Subclasses

Your body makes four distinct versions of its most abundant antibody, and each one protects you against a different category of threat. A standard blood test measures your total level of this antibody (called , or IgG), but that single number can look perfectly normal even when one version is dangerously low. The IgG Subclasses panel splits the total into its four components so you can see where, specifically, your immune defense may be falling short.

This panel also works in the opposite direction. When one subclass runs unusually high, particularly the fourth type (IgG4), it can signal a distinct inflammatory condition that quietly damages organs over months or years. Whether the concern is unexplained infections or unexplained inflammation, this panel gives you a resolution that total IgG alone cannot provide.

What This Panel Reveals

IgG is the workhorse of your immune system, making up roughly 75% of all the antibodies circulating in your blood. But that single label covers four specialized subtypes, each carrying a different job. IgG1 is the most abundant, accounting for about 60% to 70% of total IgG, and it targets protein-based threats like viruses and bacterial toxins. IgG2, at roughly 20% to 30%, specializes in defending against bacteria that wear a sugar-coated shield (called a polysaccharide capsule), including Streptococcus pneumoniae and Haemophilus influenzae.

IgG3, the smallest fraction at about 5% to 8%, is the most potent activator of the complement system, a cascade of proteins that punches holes in invaders. It responds early to viral infections and clears them aggressively but has a much shorter lifespan in the blood (about 7 days versus 21 days for the others). IgG4, the rarest at 1% to 4%, normally plays a quiet anti-inflammatory role. When IgG4 levels climb well above normal, it can indicate a specific immune-mediated disease that causes tissue swelling and scarring in organs like the pancreas, salivary glands, kidneys, and bile ducts.

Why Total IgG Is Not Enough

A person can have a completely normal total IgG and still carry a significant subclass deficiency. Studies of adults with recurrent sinopulmonary infections (repeated sinus, ear, or lung infections) have found IgG subclass deficiencies in 15% to 20% of those evaluated, even when their total IgG fell within the normal range. The most common isolated deficiency in adults is IgG3, followed by IgG1 and IgG2.

IgG2 deficiency specifically impairs your defense against bacteria with sugar-coated capsules. In studies of adults with recurrent infections from these bacteria, a disproportionate number had low IgG2 levels that would have been invisible on a standard immunoglobulin panel. This is the core reason the subclass panel exists: it catches vulnerabilities that the aggregate number masks.

How to Read Your Results Together

Interpreting this panel means looking at the pattern across all four values, not any single result in isolation. A low number in one subclass with normal levels in the others has a different clinical meaning than multiple subclasses running low together.

A low subclass level alone does not always mean disease. Roughly 2% to 5% of healthy adults have at least one subclass below the reference range without any clinical symptoms. The results become clinically meaningful when a low subclass lines up with a pattern of recurrent infections, poor vaccine responses, or unexplained organ inflammation.

When Results Can Be Misleading

Several factors can shift subclass levels temporarily. Immunosuppressive medications, including corticosteroids (strong anti-inflammatory steroids) and certain biologic drugs, can lower one or more subclasses. Smoking has been associated with reduced IgG2 levels. Acute infections can transiently raise IgG1 and IgG3, since these are the first responders. If you test during an active infection, those values may look artificially high while masking a baseline deficiency.

Age also matters. IgG2 and IgG4 mature more slowly during childhood and do not reach adult levels until the late teenage years. Interpreting subclass results in anyone under 18 requires age-adjusted reference ranges that differ substantially from adult cutoffs. In older adults, mild declines in IgG1 and IgG3 may reflect normal immune aging (immunosenescence) rather than a primary deficiency.

IgG4-Related Disease: The High-End Signal

Elevated IgG4 has become one of the most clinically significant findings this panel can produce. IgG4-related disease (IgG4-RD) is a condition in which immune cells infiltrate and scar organs, sometimes simultaneously in several locations. It can affect the pancreas (causing autoimmune pancreatitis), the bile ducts, salivary and tear glands, kidneys, aorta, and the tissue surrounding the kidneys and other deep abdominal organs. A 2012 epidemiological study in Japan estimated the prevalence at roughly 0.28 to 1.08 per 100,000 people, though many experts believe it is underdiagnosed worldwide.

Serum IgG4 levels above 135 mg/dL are commonly used as a screening threshold, but this number alone is neither sensitive nor specific enough for diagnosis. In one prospective cohort study, an elevated serum IgG4 had a sensitivity of about 90% but a specificity of only 60% for IgG4-RD, meaning other conditions (allergies, infections, certain cancers) can also push IgG4 up. The 2019 ACR/EULAR (American College of Rheumatology/European Alliance of Associations for Rheumatology) classification criteria for IgG4-RD incorporate clinical, serological, and pathological findings together. A high IgG4 on this panel is a starting point for evaluation, not a diagnosis by itself.

Tracking Over Time

A single subclass panel establishes your baseline. Serial testing, typically every 6 to 12 months, reveals whether a borderline deficiency is stable or worsening, and whether an intervention (such as immunoglobulin replacement therapy or vaccination) is having its intended effect. For those being monitored for IgG4-RD, tracking IgG4 levels over time helps assess treatment response to corticosteroids or targeted drugs like rituximab.

Trends matter more than any single value. A slowly falling IgG2 over two or three draws, even if each value is still technically within range, may warrant a functional antibody test (checking whether you mount a protective response to vaccines) before waiting for a frank deficiency to develop.

What to Do with Your Results

If all four subclass values are within normal limits and you have no recurrent infections or unexplained inflammation, your immune antibody profile is reassuring. Recheck annually or as part of periodic screening if you have a personal or family history of immune-related issues.

If one or more subclasses are low, the next step is a functional test: your doctor can administer a vaccine against common pneumonia-causing bacteria and measure your antibody response 4 to 6 weeks later. A poor response confirms that the low number reflects a real functional gap, not just natural variation. From there, an immunologist can discuss whether prophylactic antibiotics, aggressive vaccination strategies, or immunoglobulin replacement therapy is appropriate.

If IgG4 is elevated, especially above twice the upper limit of normal, follow up with imaging (often a CT scan or MRI of the abdomen and chest) and referral to a rheumatologist or immunologist. Early treatment of IgG4-RD can prevent irreversible organ scarring.